FDA Approves Journavx, New Nonopioid Med, for Acute Pain

Category: Health

Vertex Pharmaceuticals has received FDA approval for Journavx (suzetrigine), a non-opioid medication for moderate to severe acute pain in adults. This first-in-class drug targets the NaV1.8 pain-signaling receptor to prevent pain signals from reaching the brain, providing an alternative to opioids. With over 80 million Americans prescribed for acute pain annually, Journavx aims to reduce the risks associated with opioid use, including addiction. The approval is based on clinical trials showing significant pain reduction, and the drug is priced at $15.50 per 50 mg pill.

Keywords: Journavx, Vertex Pharmaceuticals, non-opioid pain management

Source: Managed Healthcare Executive

Update At: 2/1/2025

Related Sources

Officials in North Korea seek medicine for Kim’s health problems related to obesity, Seoul says

Kim Jong Un's health is deteriorating, with South Korean officials reporting he is now 308 pounds, suffering from high blood pressure and diabetes. His health issues are attributed to stress, smoking, and drinking, raising concerns about hereditary cardiovascular diseases. Speculation surrounds his search for foreign medicines and potential successors, particularly his daughter Kim Ju Ae.

NBC News

FDA approves blood test for colon cancer

The FDA has approved Guardant Health's Shield blood test as a primary screening tool for colon cancer in individuals aged 45 and older at average risk. The test shows 83% sensitivity for detecting colorectal cancer and meets Medicare coverage requirements. This approval is expected to enhance early detection and improve screening rates for colon cancer, which has a high survival rate when caught early.

WEAU

New blood test for colorectal cancer approved by FDA

The FDA has approved a new blood test called Shield for screening colorectal cancer, aimed at increasing screening rates among adults aged 45 and up. While it is not a replacement for colonoscopies, Shield offers a less invasive method to identify potential cancer cases through DNA analysis from blood samples. The test has shown 83% sensitivity for detecting colorectal cancer but has limitations in identifying advanced precancerous polyps. Follow-up colonoscopies are necessary for confirmation of positive results.

Live Science

New blood test to detect colorectal cancer is a game changer, doctor explains

The FDA has approved a new blood test called Shield for colorectal cancer screening in adults 45 and older at average risk, which could significantly improve early detection and treatment outcomes.

CBS News

Saskatchewan's crime rate top of Canada for 25th straight year: Stats Canada

Newfoundland and Labrador government increases financial assistance for low-income residents needing burial or cremation services due to a rise in unclaimed bodies.

CTV News Regina

Recall of Boar's Head Deli Meats Follows Sample Test for Listeria at Maryland Store

U.S. health officials announced a recall of Boar’s Head liverwurst and deli meats due to a listeria outbreak linked to 34 illnesses and 2 deaths. The recall affects over 200,000 pounds of products, including various deli meats with specific sell-by dates. Consumers are advised to discard the recalled items and clean their refrigerators to prevent contamination.

Insurance Journal

Dr. Roach: At-home testing is not a comprehensive solution for everyone

DIY home health care tests, such as at-home COVID tests, can provide quick results and improve access to care, but they also pose challenges in interpreting results and may lead to false positives or negatives. While some tests, like A1C for diabetes, are beneficial, the lack of regulation and potential for errors highlight that DIY testing is not a complete solution for healthcare access issues.

The Detroit News

Boar's Head Recall Tied to Listeria Expands to 7 Million More Pounds of Deli Meat

Boars Head deli meats recall expanded to 7 million pounds due to potential Listeria contamination, with 34 reported cases and two deaths. The recall includes various meat products and affects those at higher risk, such as pregnant women and the elderly. Consumers are advised to discard recalled items and clean their refrigerators to prevent cross-contamination.

HealthDay

Map shows 13 states with listeria cases linked to Boar's Head recall

The FDA has expanded a recall of deli meats potentially contaminated with listeria, linked to an outbreak causing two deaths and 33 hospitalizations across 13 states. Virginia-based Boar's Head is recalling over 7 million pounds of various meat products after listeria was found in their liverwurst. The CDC is investigating the outbreak, which has affected individuals aged 32 to 94.

USA TODAY

What to know about the Boar’s Head meat recall and listeria outbreak

A listeria outbreak linked to Boar's Head products has resulted in two deaths and 33 hospitalizations across 13 states. The affected meat, packaged between May 10 and July 29, includes items like ham, hot dogs, bologna, and bacon. Customers are advised to discard or return recalled products for a refund. The outbreak poses significant risks, especially to the elderly and pregnant individuals.

The Washington Post